MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
5.50
+0.05
+0.92%
After Hours: 5.40 -0.1 -1.82% 20:05 09/22 EDT
OPEN
5.45
PREV CLOSE
5.45
HIGH
5.59
LOW
5.32
VOLUME
83.93K
TURNOVER
0
52 WEEK HIGH
8.22
52 WEEK LOW
3.300
MARKET CAP
141.77M
P/E (TTM)
-4.7170
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CAPR last week (0911-0915)?
Weekly Report · 6d ago
Weekly Report: what happened at CAPR last week (0904-0908)?
Weekly Report · 09/11 12:15
Capricor Therapeutics Inc: Initial statement of beneficial ownership of securities
Press release · 09/07 00:10
Weekly Report: what happened at CAPR last week (0828-0901)?
Weekly Report · 09/05 10:17
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 08/29 17:31
Weekly Report: what happened at CAPR last week (0821-0825)?
Weekly Report · 08/28 12:24
Top 5 Health Care Stocks That May Fall Off A Cliff
Benzinga · 08/23 11:58
Capricor: Q4 2023 Interim Analysis For DMD Treatment Makes This A Must Watch
Seeking Alpha · 08/16 13:31
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). CAP-1002 is designed to slow disease progression in DMD through the immunomodulatory, anti-inflammatory, and anti-fibrotic actions of cardiosphere-derived cells (CDCs), which are mediated by secreted exosomes laden with bioactive cargo. CAP-2003 is the name of its exosomes product candidate, which is derived from its CDCs. It is also developing its exosome technology as a therapeutic platform. The Company’s focus is on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA), as well as proteins to treat or prevent a variety of diseases.

Webull offers kinds of Capricor Therapeutics Inc stock information, including NASDAQ:CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.